Navigation Links
DURECT Corporation Invites You to Join Its Second Quarter 2008 Earnings Conference Call
Date:7/30/2008

CUPERTINO, Calif., July 30 /PRNewswire-FirstCall/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) second quarter 2008 financial results press release, you are invited to listen to the conference call that will be broadcast live over the Internet on Wednesday, August 6, 2008 at 9:00 a.m. EDT (6:00 a.m. PDT).

(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)

A live audio webcast of the presentation will be available by accessing DURECT's homepage at http://www.durect.com and clicking "Investor Relations." If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.

About DURECT Corporation

DURECT is an emerging specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, with late-stage development programs including Remoxy(TM), POSIDUR(TM), ELADUR(TM), and TRANSDUR(TM)-Sufentanil. DURECT's proprietary oral, transdermal and injectable depot delivery technologies enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs. For more information, please visit http://www.durect.com.

NOTE: POSIDUR(TM), SABER(TM), ORADUR(TM), TRANSDUR(TM), and ELADUR(TM) are trademarks of DURECT Corporation. Other referenced trademarks belong to their respective owners. Remoxy, POSIDUR, ELADUR and TRANSDUR-Sufentanil are drug candidates under development and have not been approved for commercialization by the US Food and Drug Administration or other health authorities.


'/>"/>
SOURCE DURECT Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. DURECT Corporation Presenting at the 2008 UBS Global Generic and Specialty Pharmaceuticals Conference
2. DURECT Corporation Invites You to Join Its First Quarter 2008 Earnings Conference Call
3. DURECT to Participate in Morgan Stanley Global Healthcare Conference
4. DURECT Provides Update on CHRONOGESIC(R) Research Program
5. DURECT to Participate in Cowen Annual Healthcare Conference
6. DURECT to Participate in Susquehanna Financial Healthcare Conference
7. DURECT to Present at BIO CEO Investor Conference 2008
8. DURECT to Present at 2007 BIO Investor Forum
9. DURECT to Present at UBS Global Life Sciences Conference
10. DURECT to Present at Merriman Curhan Fords Annual Investor Summit
11. STERIS Corporation Announces Fiscal 2009 First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... ... The International Essential Tremor Foundation (IETF) will host a free educational forum ... will take place on Saturday, Aug. 26 at the Embassy Suites by Hilton Cleveland ... 9 a.m. to 12 p.m., with check-in beginning at 8 a.m. The event is ...
(Date:7/24/2017)... ... July 24, 2017 , ... The Topricin Companies, ... awareness for Topricin’s revolutionary, natural, after-burn skin care product, Topricin After Burn Cream. ... of long term skin conditions, including cancer. In the short term, overexposure ...
(Date:7/24/2017)... Beach, California (PRWEB) , ... July 24, 2017 ... ... commercialization of autologous fat (adipose) transfer systems announces the issuance of United States ... ‘324 patent) for its adipose filtration technology. The '398 and '324 patents ...
(Date:7/24/2017)... , ... July 24, 2017 , ... Sharon Kleyne, host ... and Your Health on VoiceAmerica sponsored by Nature’s Tears® EyeMist® recently talked on the ... of myopia in China. , The article by Zidor Aldama described the situation in ...
(Date:7/24/2017)... Calif. (PRWEB) , ... July 24, 2017 , ... A ... from food addiction to sexual abuse, and how she has overcome them. “Forbidden Memories: ... instances in her life and how she has risen above. , In “Memories,” readers ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)...  Endo International plc (NASDAQ: ENDP ) ... its manufacturing network, the Company will be ceasing operations ... Huntsville, Alabama . The closure of the ... 12 to 18 months. The Huntsville ... commoditized products and these restructuring actions are intended to ...
(Date:7/17/2017)... , July 17, 2017  MedX Holdings, Inc., ... medical testing, strengthening and rehabilitation equipment, today announced the ... Program. MedX is considered the gold standard for the ... in specialized medical strengthening equipment. ... lease with the physician or practice who prescribe the ...
(Date:7/13/2017)... -- Centurion Medical Products, a leader in medical product innovation and global ... device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part of a hospice,s ... while preventing unneeded emergency department admission due to severe fecal impaction. ...
Breaking Medicine Technology: